Has anyone seen the recent Cowen Report? I hear it is not positive. Were they not their bankers? Odd to get a unfavorable report even though there is supposedly a firewall between the banker and the analyst in the firm.
While he/they are PROBABLY bashers, he is not making up the "more robust" quote from Singh. Evs, you have always been the voice of reason here, and that includes calming down the pumpers. That quote by Singh definitely gives me pause.
So what "clown" 16 patients is the only red flag. Every idiot knows that PI is a safety trial. If they were blatantly cherry-picking, the ave. age of the subjects would be far from the norm - it wasn't. Also, it conveniently goes unmentioned that antigen levels in PII bode extremely well, and that the treatment is working as designed. Furthermore, you and your minions, should refine your spamming style. The A.Hour and very early P.mkt. thread construction is a bigger red flag than anything mentioned by you and your robots, I know this game intimately but I appreciate the the the ability you provide to mass-"ignore". See you @ the circus "clown".
You are correct Cowen and Co carried the book on the Ayer capital deal. That was in January. On Feb 16th this year Cowen intiated coverage and rated IMUC as neutral. On feb 16th the stock price was 1.88 on March 4th it was $2.37. Cowen also invited them to present at there investment conference in June. Obviously they missed the analyst call..but then again since they carried the book I suppose they also could not dare be a homer..neutral..is lame. I don't make anything out of the rating as a first call..even though they missed a slow fastball down the middle. The current range on all coverage is $4.50 to $8.50..They get a positive P2 and its a $40.00 stock..glta.